Last reviewed · How we verify

Oxycodone and acetaminophen

University of Puerto Rico · FDA-approved active Small molecule

Oxycodone binds to opioid receptors to reduce pain perception, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects.

Oxycodone binds to opioid receptors to reduce pain perception, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects. Used for Moderate to severe acute pain, Moderate to severe chronic pain.

At a glance

Generic nameOxycodone and acetaminophen
SponsorUniversity of Puerto Rico
Drug classOpioid analgesic combination
TargetMu opioid receptor (oxycodone); cyclooxygenase enzymes (acetaminophen)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Oxycodone is a semi-synthetic opioid agonist that acts on mu, delta, and kappa opioid receptors in the central nervous system to modulate pain signals. Acetaminophen works through a separate mechanism, inhibiting cyclooxygenase enzymes and reducing prostaglandin production, providing complementary pain relief and fever reduction. The combination allows for enhanced analgesia at lower opioid doses.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: